Case: Glenayre Elec Inc v. Jackson, 1:02-cv-00256 (federal).
Litigation summary and patent-style analysis: not produced. No case-identifying filings, claims, parties’ roles (plaintiff/defendant), asserted legal theories, docket outcomes, or court documents are provided in the prompt, and the record is insufficient to generate a complete and accurate litigation analysis.
Litigation docket summary and case posture: Glenayre Elec Inc v. Jackson, 1:02-cv-00256
Featured snippet: Not available from the provided information.
What is the procedural posture?
Unknown from provided inputs: filing date, assigned judge, motion practice, stay status, remand, amendments, or disposition.
What claims and legal theories were asserted?
Unknown from provided inputs: whether the case involves patent infringement, trade secret, contract, unfair competition, copyright, or other IP/non-IP claims.
What relief was sought?
Unknown from provided inputs: damages, injunctive relief, declaratory judgment, attorneys’ fees, or other remedies.
What was the final disposition?
Unknown from provided inputs: dismissal vs. summary judgment vs. default judgment vs. settlement vs. voluntary discontinuance.
What patents or IP rights were allegedly infringed in Glenayre Elec Inc v. Jackson?
Featured snippet: Not available from the provided information.
Which patents were asserted?
Not provided: patent numbers, application numbers, publication numbers, ownership/assignee chain, expiration dates, or priority data.
Which accused products or acts were at issue?
Not provided: model names/serials, product categories, manufacturing locations, importation, sales channels, or user methods.
What did the court decide on key motions in 1:02-cv-00256?
Featured snippet: Not available from the provided information.
Motion to dismiss under Rule 12(b)
Not provided: grounds (lack of jurisdiction, improper venue, failure to state a claim, preemption, indefiniteness, claim construction issues).
Summary judgment
Not provided: claim construction rulings, infringement/non-infringement findings, validity rulings, or standard-of-review decisions.
Injunction or temporary restraining order
Not provided: TRO/PI filings, bond, irreparable harm findings, likelihood of success, or public interest analysis.
Settlement and licensing outcomes: Did Glenayre Elec Inc settle with Jackson in 1:02-cv-00256?
Featured snippet: Not available from the provided information.
Was there a consent judgment or stipulation?
Not provided: settlement agreement terms, confidentiality, release scope, covenant-not-to-sue, or remaining claims.
Did the case trigger any cross-licensing or assignments?
Not provided: assignment records, Sublicense terms, or post-settlement amendments.
Appeal risk and appellate history for 1:02-cv-00256
Featured snippet: Not available from the provided information.
Was there an appeal?
Not provided: notice of appeal, docket on appeal, or appellate outcome.
Commercial and enforcement impact: What does 1:02-cv-00256 mean for IP enforcement strategy?
Featured snippet: Not available from the provided information.
Enforcement lessons
Not provided: court findings that strengthen or weaken Glenayre’s enforcement posture (claim clarity, evidence sufficiency, jurisdiction, infringement proof).
Practical implications for future defendants
Not provided: barriers identified by the court (invalidity exposure, pleading defects, venue/jurisdiction limits, evidentiary gaps).
Key Takeaways
Litigation summary cannot be completed from the provided prompt because no docket details, court orders, or substantive allegations are included.
FAQs
What court has jurisdiction in Glenayre Elec Inc v. Jackson, 1:02-cv-00256?
What claims were asserted in 1:02-cv-00256?
Were any patents involved, and which ones?
Did the parties settle, and what was released?
Was there a decision on injunction, damages, or validity?
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
